Wednesday, 9 January 2019

Peter Meldrum, Who Lost a Fight to Patent Genes, Dies at 71

He led Myriad Genetics, whose patents on the BRCA1 and BRCA2 genes, associated with breast cancer, were invalidated by the Supreme Court.

Related Posts: